Clear Street’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34K Sell
46,490
-200
-0.4% -$5 ﹤0.01% 1038
2025
Q4
$528 Sell
46,690
-100
-0.2% -$2 ﹤0.01% 883
2025
Q3
$1.27K Buy
46,790
+100
+0.2% +$4 ﹤0.01% 766
2025
Q2
$929 Sell
46,690
-404
-0.9% -$13 ﹤0.01% 612
2025
Q1
$1.65K Sell
47,094
-200
-0.4% -$7 ﹤0.01% 473
2024
Q4
$974 Sell
47,294
-300
-0.6% -$10 ﹤0.01% 491
2024
Q3
$2.06K Sell
47,594
-100
-0.2% -$7 ﹤0.01% 551
2024
Q2
$2.58K Sell
47,694
-300
-0.6% -$25 ﹤0.01% 574
2024
Q1
$7.01K Sell
47,994
-17,342
-27% -$2.06K ﹤0.01% 466
2023
Q4
$1.99K Sell
65,336
-100
-0.2% -$4 ﹤0.01% 555
2023
Q3
$923 Sell
65,436
-26,636
-29% -$706 ﹤0.01% 894
2023
Q2
$3.36K Hold
92,072
﹤0.01% 880
2023
Q1
$6.78K Hold
92,072
﹤0.01% 605
2022
Q4
$8K Buy
+92,072
New +$9.18K ﹤0.01% 562

Other funds holding ICUCW

Clear Street's ICUCW Position: Q1 2026 in Review

Clear Street reduced its SeaStar Medical Holding Corp Warrant (ICUCW) stake by 0.43% in Q1 2026, selling an estimated $5 and leaving 46,490 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Clear Street first reported a position in ICUCW in Q4 2022 and has held it in 14 quarters since. The position peaked at $8K in Q4 2022. 10 funds tracked by Wall St. Rank hold ICUCW as of Q1 2026.

  • Clear Street held 46,490 shares of SeaStar Medical Holding Corp Warrant worth $1.34K as of Q1 2026.
  • Clear Street sold 200 SeaStar Medical Holding Corp Warrant shares in Q1 2026, an estimated $5.
  • SeaStar Medical Holding Corp Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1038 holding.
  • Clear Street first reported a position in SeaStar Medical Holding Corp Warrant in Q4 2022 and has held it in 14 quarters since.
  • Clear Street's SeaStar Medical Holding Corp Warrant position peaked at $8K in Q4 2022.
  • 10 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.